Transfusion-free techniques in pediatric live donor liver transplantation

Journal of Pediatric Gastroenterology and Nutrition

Volumn 40, Issue 4, 2005, Pages 521-523

  Jabbour, Nicolas ^a   Gagandeep, Singh ^b   Thomas, Daniel ^b   Stapfer, Maria ^b   Mateo, Rodrigo ^b   Sher, Linda ^b   Selby, Rick ^b   Genyk, Yuri ^b  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

APROTININ; DESMOPRESSIN ACETATE; ERYTHROPOIETIN; FERROUS SULFATE; FOLIC ACID; IMMUNOSUPPRESSIVE AGENT; MULTIVITAMIN; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; STEROID; TACROLIMUS;

ARTICLE; BILE DUCT ATRESIA; BLEEDING; BLOOD TRANSFUSION; CASE REPORT; CHILD; DRUG HALF LIFE; FEMALE; FOLLOW UP; HEMATOCRIT; HEMATOLOGICAL PARAMETERS; HEPATOJEJUNOSTOMY; HUMAN; INFANT; JEHOVAH'S WITNESS; LIVER DISEASE; LIVER FUNCTION TEST; LIVER GRAFT REJECTION; LIVER RESECTION; LIVER TRANSPLANTATION; LIVING DONOR; MALE; OPERATION DURATION; PEDIATRIC SURGERY; PORTOENTEROSTOMY; POSTOPERATIVE CARE; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RELIGIOUS GROUP; TREATMENT OUTCOME;

BLOOD TRANSFUSION; CHILD, PRESCHOOL; ERYTHROPOIETIN; FEMALE; GRAFT SURVIVAL; HEMODILUTION; HUMANS; INFANT; JEHOVAH'S WITNESSES; LIVER DISEASES; LIVER TRANSPLANTATION; LIVING DONORS; MALE; POSTOPERATIVE CARE; PREOPERATIVE CARE; RELIGION AND MEDICINE; TREATMENT OUTCOME;

EID: 16844370326     PISSN: 02772116     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.MPG.0000157590.23126.FD     Document Type: Article

References (15)

1. Jabbour N, Gagandeep S, Mateo R, et al. Live donor liver transplantation without blood products: Strategies developed for Jehovah's Witnesses offer broad application. Ann Surg 2004;240:350-7.
2. Schroeder RA, Johnson LB, Plotkin JS, et al. Total blood transfusion and mortality after orthotopic liver transplantation. Anesthesiology 1999;91:329-30.
3. URREA; UNOS. 2002 Annual Report of the U. S. Organ Procurement and Transplantation Network and the Scientific Registry of Transplant Recipients: Transplant Data 1992-2001 [Internet]. Rockville, MD: HHS/HRSA/OSP/DOT; 2003 Available at: http://www.ustransplant.org/annual.html.
4. Dalmau A, Sabate A, Acosta F, et al. Tranexamic acid reduces red cell transfusion better than epsilon-aminocaproic acid or placebo in liver transplantation. Anesth Analg 2000;91:29-34.
5. Porte RJ, Molenaar IQ, Begliomini B, et al. Aprotinin and transfusion requirements in orthotopic liver transplantation: a multicentre randomized double-blind study. Lancet 2000;355(9212): 1303-9.
6. Hendriks HG, Meijer K, de Wolf JT, et al. Reduced transfusion requirements by recombinant factor VIIa in orthotopic liver transplantation: A pilot study. Transplantation 2001;71:402-5.
7. Sacks DA, Koppes RH. Caring for the female Jehovah's Witness: balancing medicine, ethics, and the first amendment. Am J Obstet Gynecol 1994;170:452-5.
8. Muramoto O. Jehovah's Witnesses and blood transfusions. Lancet 1998;352(9130):824.
9. Adamson J. Erythropoietin, iron metabolism, and red blood cell production. Semin Hematol 1996;33Suppl 2:5-9.
10. Goldberg MA. Erythropoiesis, erythropoietin, and iron metabolism in elective surgery: preoperative strategies for avoiding allogeneic blood exposure. Am J Surg 1995;170(6S):37S-43.
11. Snook NJ, O'Beirne HA, Enright S, et al. Use of recombinant human erythropoietin to facilitate liver transplantation in a Jehovah's Witness. Br J Anaesth 1996;76:740-3.
12. Matot I, Scheinin O, Jurim O, Eid A. Effectiveness of acute normovolemic hemodilution to minimize allogeneic blood transfusion in major liver resections. Anesthesiology 2002;97:794-800.
13. Spain DA, Miller FB, Bergamini TM, et al. Quality assessment of intraoperative blood salvage and autotransfusion. Am Surg 1997;63:1059-63.
14. Sloand EM, Pitt E, Klein HG. Safety of the Blood Supply. JAMA 1995;274:1368-73.
15. Schreiber GB, Busch MP, Kleinman SH, et al. The risk of transfusion-transmitted viral infections. The Retrovirus Epidemiology Donor Study. N Engl J Med 1996;334:1685-90.